Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
Glial progenitor cell-based treatment and modeling of neurological disease.
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Cognitive functioning in pediatric transverse myelitis.
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
Therapy optimization: a new model for managing high-cost biologics.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.
Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
Functional brain networks: Linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG Study.
Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Relapses and disability accumulation in progressive multiple sclerosis.
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
The role of IL-6 in the expression of PD-1 and PDL-1 on CNS cells following infection with Theiler's murine encephalomyelitis virus.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
How do immune cells support and shape the brain in health, disease, and aging?
Pregnancy, sex and hormonal factors in multiple sclerosis.
[Microglia in pathophysiology of neuroimmunological disorders].
Pages
« first
‹ previous
…
318
319
320
321
322
323
324
325
326
…
next ›
last »